Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 288

1.

Chronic Disease Medication Adherence After Initiation of Buprenorphine for Opioid Use Disorder.

Chang HY, Daubresse M, Saloner B, Alexander GC.

Med Care. 2019 Sep;57(9):667-672. doi: 10.1097/MLR.0000000000001165.

PMID:
31404013
2.

Prescription drug monitoring programs: Assessing the association between "best practices" and opioid use in Medicare.

Moyo P, Simoni-Wastila L, Griffin BA, Harrington D, Alexander GC, Palumbo F, Onukwugha E.

Health Serv Res. 2019 Aug 2. doi: 10.1111/1475-6773.13197. [Epub ahead of print]

PMID:
31372990
3.

Initial Opioid Prescriptions among U.S. Patients, 2012-2017.

Alexander GC, Kolodny A.

N Engl J Med. 2019 Jun 27;380(26):2587. doi: 10.1056/NEJMc1905100. No abstract available.

PMID:
31242377
4.

Clean indoor air laws, cigarette excise taxes, and smoking: Results from the current population survey-tobacco use supplement, 2003-2011.

Mojtabai R, Riehm KE, Cohen JE, Alexander GC, Rutkow L.

Prev Med. 2019 Sep;126:105744. doi: 10.1016/j.ypmed.2019.06.002. Epub 2019 Jun 4.

PMID:
31173803
5.

Availability and Cost of Naloxone Nasal Spray at Pharmacies in Philadelphia, Pennsylvania, 2017.

Guadamuz JS, Alexander GC, Chaudhri T, Trotzky-Sirr R, Qato DM.

JAMA Netw Open. 2019 Jun 5;2(6):e195388. doi: 10.1001/jamanetworkopen.2019.5388.

6.

Association of new opioid continuation with surgical specialty and type in the United States.

Bicket MC, Murimi IB, Mansour O, Wu CL, Alexander GC.

Am J Surg. 2019 Apr 15. pii: S0002-9610(19)30127-8. doi: 10.1016/j.amjsurg.2019.04.010. [Epub ahead of print]

PMID:
31023548
7.

Association Between Pharmacy Closures and Adherence to Cardiovascular Medications Among Older US Adults.

Qato DM, Alexander GC, Chakraborty A, Guadamuz JS, Jackson JW.

JAMA Netw Open. 2019 Apr 5;2(4):e192606. doi: 10.1001/jamanetworkopen.2019.2606.

8.

Globalization of clinical trials: Variation in estimated regional costs of pivotal trials, 2015-2016.

Qiao Y, Alexander GC, Moore TJ.

Clin Trials. 2019 Jun;16(3):329-333. doi: 10.1177/1740774519839391. Epub 2019 Mar 29.

PMID:
30922113
9.

Reducing High-Dose Opioid Prescribing: State-Level Morphine Equivalent Daily Dose Policies, 2007-2017.

Heins SE, Frey KP, Alexander GC, Castillo RC.

Pain Med. 2019 Mar 13. pii: pnz038. doi: 10.1093/pm/pnz038. [Epub ahead of print]

PMID:
30865779
10.

Medicaid trends in prescription opioid and non-opioid use by HIV status.

Canan C, Alexander GC, Moore R, Murimi I, Chander G, Lau B.

Drug Alcohol Depend. 2019 Apr 1;197:141-148. doi: 10.1016/j.drugalcdep.2018.11.034. Epub 2019 Feb 13.

PMID:
30825794
11.

Assessment of the FDA Risk Evaluation and Mitigation Strategy for Transmucosal Immediate-Release Fentanyl Products.

Rollman JE, Heyward J, Olson L, Lurie P, Sharfstein J, Alexander GC.

JAMA. 2019 Feb 19;321(7):676-685. doi: 10.1001/jama.2019.0235.

12.

Use of non-insulin diabetes medicines after insulin initiation: A retrospective cohort study.

Xu Y, Pilla SJ, Alexander GC, Murimi IB.

PLoS One. 2019 Feb 13;14(2):e0211820. doi: 10.1371/journal.pone.0211820. eCollection 2019.

13.

Use of Population Pharmacokinetic Analyses Among FDA-Approved Biologics.

Ogasawara K, Alexander GC.

Clin Pharmacol Drug Dev. 2019 Feb 1. doi: 10.1002/cpdd.658. [Epub ahead of print]

PMID:
30707505
14.

Differences in National Diabetes Treatment Patterns and Trends between Older and Younger Adults.

Pilla SJ, Segal JB, Alexander GC, Boyd CM, Maruthur NM.

J Am Geriatr Soc. 2019 May;67(5):1066-1073. doi: 10.1111/jgs.15790. Epub 2019 Jan 31.

15.

Coverage of Nonpharmacologic Treatments for Low Back Pain Among US Public and Private Insurers.

Heyward J, Jones CM, Compton WM, Lin DH, Losby JL, Murimi IB, Baldwin GT, Ballreich JM, Thomas DA, Bicket MC, Porter L, Tierce JC, Alexander GC.

JAMA Netw Open. 2018 Oct 5;1(6):e183044. doi: 10.1001/jamanetworkopen.2018.3044.

16.

Changes in Buprenorphine-Naloxone and Opioid Pain Reliever Prescriptions After the Affordable Care Act Medicaid Expansion.

Saloner B, Levin J, Chang HY, Jones C, Alexander GC.

JAMA Netw Open. 2018 Aug 3;1(4):e181588. doi: 10.1001/jamanetworkopen.2018.1588.

17.

Prescription Drug Coverage for Treatment of Low Back Pain Among US Medicaid, Medicare Advantage, and Commercial Insurers.

Lin DH, Jones CM, Compton WM, Heyward J, Losby JL, Murimi IB, Baldwin GT, Ballreich JM, Thomas DA, Bicket M, Porter L, Tierce JC, Alexander GC.

JAMA Netw Open. 2018 Jun 1;1(2):e180235. doi: 10.1001/jamanetworkopen.2018.0235.

18.

Trends in Opioid Prescribing Among Hemodialysis Patients, 2007-2014.

Daubresse M, Alexander GC, Crews DC, Segev DL, McAdams-DeMarco MA.

Am J Nephrol. 2019;49(1):20-31. doi: 10.1159/000495353. Epub 2018 Dec 13.

PMID:
30544114
19.

Clinical Development of Biologics Approved by the US Food and Drug Administration, 2003-2016.

Alexander GC, Ogasawara K, Wiegand D, Lin D, Breder CD.

Ther Innov Regul Sci. 2018 Dec 3:2168479018812058. doi: 10.1177/2168479018812058. [Epub ahead of print]

PMID:
30509142
20.

Recent Progress in Vascular Tissue-Engineered Blood Vessels.

Chen J, Alexander GC, Bobba PS, Jun HW.

Adv Exp Med Biol. 2018;1064:123-144. doi: 10.1007/978-981-13-0445-3_8. Review.

PMID:
30471030
21.

A More Balanced Approach to Dietary Supplement Data-Reply.

Qato DM, Alexander GC, Lindau ST.

JAMA Pediatr. 2019 Jan 1;173(1):104-105. doi: 10.1001/jamapediatrics.2018.4032. No abstract available.

PMID:
30419136
22.

Prevalence of Opioid, Gabapentinoid, and NSAID Use in Patients with CKD.

Novick TK, Surapaneni A, Shin JI, Ballew SH, Alexander GC, Inker LA, Chang AR, Grams ME.

Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1886-1888. doi: 10.2215/CJN.08530718. Epub 2018 Nov 8. No abstract available.

PMID:
30409899
23.

Estimated Costs of Pivotal Trials for Novel Therapeutic Agents Approved by the US Food and Drug Administration, 2015-2016.

Moore TJ, Zhang H, Anderson G, Alexander GC.

JAMA Intern Med. 2018 Nov 1;178(11):1451-1457. doi: 10.1001/jamainternmed.2018.3931.

PMID:
30264133
24.

Using trajectory models to assess the effect of hydrocodone upscheduling among chronic hydrocodone users.

Murimi IB, Chang HY, Bicket M, Jones CM, Alexander GC.

Pharmacoepidemiol Drug Saf. 2019 Jan;28(1):70-79. doi: 10.1002/pds.4639. Epub 2018 Sep 5.

PMID:
30187574
25.

Prescription Medication Use Among Children and Adolescents in the United States.

Qato DM, Alexander GC, Guadamuz JS, Lindau ST.

Pediatrics. 2018 Sep;142(3). pii: e20181042. doi: 10.1542/peds.2018-1042.

PMID:
30150214
26.

Association Between Sodium-Glucose Cotransporter 2 Inhibitors and Lower Extremity Amputation Among Patients With Type 2 Diabetes.

Chang HY, Singh S, Mansour O, Baksh S, Alexander GC.

JAMA Intern Med. 2018 Sep 1;178(9):1190-1198. doi: 10.1001/jamainternmed.2018.3034.

27.

Kidney Function, Polypharmacy, and Potentially Inappropriate Medication Use in a Community-Based Cohort of Older Adults.

Secora A, Alexander GC, Ballew SH, Coresh J, Grams ME.

Drugs Aging. 2018 Aug;35(8):735-750. doi: 10.1007/s40266-018-0563-1.

28.

Risks and Benefits of Direct Oral Anticoagulants across the Spectrum of GFR among Incident and Prevalent Patients with Atrial Fibrillation.

Shin JI, Secora A, Alexander GC, Inker LA, Coresh J, Chang AR, Grams ME.

Clin J Am Soc Nephrol. 2018 Aug 7;13(8):1144-1152. doi: 10.2215/CJN.13811217. Epub 2018 Jul 12.

29.

Moving Addiction Care to the Mainstream - Improving the Quality of Buprenorphine Treatment.

Saloner B, Stoller KB, Alexander GC.

N Engl J Med. 2018 Jul 5;379(1):4-6. doi: 10.1056/NEJMp1804059. No abstract available.

30.

Trends and Variation in Oral Anticoagulant Choice in Patients with Atrial Fibrillation, 2010-2017.

Zhu J, Alexander GC, Nazarian S, Segal JB, Wu AW.

Pharmacotherapy. 2018 Sep;38(9):907-920. doi: 10.1002/phar.2158. Epub 2018 Jul 26.

31.

Prevalence of Dietary Supplement Use in US Children and Adolescents, 2003-2014.

Qato DM, Alexander GC, Guadamuz JS, Lindau ST.

JAMA Pediatr. 2018 Aug 1;172(8):780-782. doi: 10.1001/jamapediatrics.2018.1008. No abstract available.

32.

The Value of U.S. Pharmacopeial Standards: A Review of the Literature.

Heyward J, Padula W, Tierce JC, Alexander GC.

J Pharm Sci. 2018 Oct;107(10):2611-2617. doi: 10.1016/j.xphs.2018.06.004. Epub 2018 Jun 13. Review.

PMID:
29908148
33.

Association of Metformin Use With Risk of Lactic Acidosis Across the Range of Kidney Function: A Community-Based Cohort Study.

Lazarus B, Wu A, Shin JI, Sang Y, Alexander GC, Secora A, Inker LA, Coresh J, Chang AR, Grams ME.

JAMA Intern Med. 2018 Jul 1;178(7):903-910. doi: 10.1001/jamainternmed.2018.0292.

34.

Healthcare costs and utilization associated with high-risk prescription opioid use: a retrospective cohort study.

Chang HY, Kharrazi H, Bodycombe D, Weiner JP, Alexander GC.

BMC Med. 2018 May 16;16(1):69. doi: 10.1186/s12916-018-1058-y.

35.

Clinical trial registration and reporting: a survey of academic organizations in the United States.

Mayo-Wilson E, Heyward J, Keyes A, Reynolds J, White S, Atri N, Alexander GC, Omar A, Ford DE; National Clinical Trials Registration and Results Reporting Taskforce Survey Subcommittee.

BMC Med. 2018 May 2;16(1):60. doi: 10.1186/s12916-018-1042-6.

36.

Opioid Oversupply After Joint and Spine Surgery: A Prospective Cohort Study.

Bicket MC, White E, Pronovost PJ, Wu CL, Yaster M, Alexander GC.

Anesth Analg. 2019 Feb;128(2):358-364. doi: 10.1213/ANE.0000000000003364.

PMID:
29677062
37.

Efficacy and safety of biosimilar insulins compared to their reference products: A systematic review.

Tieu C, Lucas EJ, DePaola M, Rosman L, Alexander GC.

PLoS One. 2018 Apr 18;13(4):e0195012. doi: 10.1371/journal.pone.0195012. eCollection 2018. Review.

38.

Cardiovascular safety signals with dipeptidyl peptidase-4 inhibitors: A disproportionality analysis among high-risk patients.

Baksh SN, McAdams-DeMarco M, Segal JB, Alexander GC.

Pharmacoepidemiol Drug Saf. 2018 Jun;27(6):660-667. doi: 10.1002/pds.4437. Epub 2018 Apr 14.

PMID:
29655237
39.

High-Risk Prescription Opioid Use Among People Living With HIV.

Canan CE, Chander G, Monroe AK, Gebo KA, Moore RD, Agwu AL, Alexander GC, Lau B; HIV Research Network.

J Acquir Immune Defic Syndr. 2018 Jul 1;78(3):283-290. doi: 10.1097/QAI.0000000000001690.

40.

Impact of Florida's prescription drug monitoring program and pill mill law on high-risk patients: A comparative interrupted time series analysis.

Chang HY, Murimi I, Faul M, Rutkow L, Alexander GC.

Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):422-429. doi: 10.1002/pds.4404. Epub 2018 Feb 28.

41.

Increasing uptake of comparative effectiveness and patient-centered outcomes research among stakeholders: insights from conference discussion.

Law E, Harrington R, Alexander GC, Saha S, Oehrlein E, Perfetto EM.

J Comp Eff Res. 2018 Feb;7(2):181-191. doi: 10.2217/cer-2017-0060. Epub 2018 Feb 21.

42.

Quality of Prescribing by Physicians, Nurse Practitioners, and Physician Assistants in the United States.

Jiao S, Murimi IB, Stafford RS, Mojtabai R, Alexander GC.

Pharmacotherapy. 2018 Apr;38(4):417-427. doi: 10.1002/phar.2095. Epub 2018 Mar 26.

PMID:
29457258
43.

Family caregivers' facilitation of daily adult prescription medication use.

Roter DL, Narayanan S, Smith K, Bullman R, Rausch P, Wolff JL, Alexander GC.

Patient Educ Couns. 2018 May;101(5):908-916. doi: 10.1016/j.pec.2017.12.018. Epub 2017 Dec 27.

PMID:
29352620
44.

Direct Oral Anticoagulants and Risk of Acute Kidney Injury in Patients With Atrial Fibrillation.

Shin JI, Luo S, Alexander GC, Inker LA, Coresh J, Chang AR, Grams ME.

J Am Coll Cardiol. 2018 Jan 16;71(2):251-252. doi: 10.1016/j.jacc.2017.10.089. No abstract available.

45.

AuPb2I7: A Narrow Bandgap Au3+ Iodide Semiconductor.

Alexander GCB, Fabini DH, Seshadri R, Kanatzidis MG.

Inorg Chem. 2018 Jan 16;57(2):804-810. doi: 10.1021/acs.inorgchem.7b02723. Epub 2018 Jan 2.

46.

Exposure- and Dose-response Analyses in Dose Selection and Labeling of FDA-approved Biologics.

Ogasawara K, Breder CD, Lin DH, Alexander GC.

Clin Ther. 2018 Jan;40(1):95-102.e2. doi: 10.1016/j.clinthera.2017.11.012. Epub 2017 Dec 19.

PMID:
29273471
47.

Association of Household Opioid Availability and Prescription Opioid Initiation Among Household Members.

Seamans MJ, Carey TS, Westreich DJ, Cole SR, Wheeler SB, Alexander GC, Pate V, Brookhart MA.

JAMA Intern Med. 2018 Jan 1;178(1):102-109. doi: 10.1001/jamainternmed.2017.7280.

48.

Warfarin use and the risk of stroke, bleeding, and mortality in older adults on dialysis with incident atrial fibrillation.

Tan J, Bae S, Segal JB, Zhu J, Alexander GC, Segev DL, McAdams-DeMarco M.

Nephrology (Carlton). 2019 Feb;24(2):234-244. doi: 10.1111/nep.13207.

PMID:
29219209
49.

Relationship between high-risk patients receiving prescription opioids and high-volume opioid prescribers.

Chang HY, Murimi IB, Jones CM, Alexander GC.

Addiction. 2018 Apr;113(4):677-686. doi: 10.1111/add.14068. Epub 2017 Nov 29.

PMID:
29193546
50.

Association Between Prescription Drug Insurance and Health Care Utilization Among Medicare Beneficiaries.

Alexander GC, Schiman C, Kaestner R.

Med Care Res Rev. 2018 Apr;75(2):153-174. doi: 10.1177/1077558716681920. Epub 2016 Dec 1.

PMID:
29148319

Supplemental Content

Loading ...
Support Center